Canada Life
RXII

Canada Life’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Canada Life’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-4,001
Closed -$7K – 2692
2015
Q2 		$7K Hold
4,001
– – ﹤0.01% 2564
2015
Q1 		$6K Buy
4,001
+290
+8% +$435 ﹤0.01% 2479
2014
Q4 		$6K Hold
3,711
– – ﹤0.01% 2472
2014
Q3 		$8K Buy
3,711
+410
+12% +$884 ﹤0.01% 2421
2014
Q2 		$10K Hold
3,301
– – ﹤0.01% 2317
2014
Q1 		$8K Hold
3,301
– – ﹤0.01% 2226
2013
Q4 		$16K Buy
+3,301
New +$16K ﹤0.01% 2169

Other funds holding RXII

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $3.03B AUM 104.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return